Alaunos Therapeutics (TCRT) Institutional Ownership $2.40 +0.01 (+0.42%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$2.42 +0.02 (+0.63%) As of 08/14/2025 04:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Alaunos Therapeutics (NASDAQ:TCRT)CurrentInstitutional OwnershipPercentage27.72%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$2.93M Get TCRT Insider Trade Alerts Want to know when executives and insiders are buying or selling Alaunos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TCRT Institutional Buying and Selling by Quarter Alaunos Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024MSD Partners L.P.101,010$325K0.2%-90.0%6.313% 5/20/2024 Virtu Financial LLC15,440$28K0.0%N/A0.096% 5/2/2024 Magnolia Capital Advisors LLC24,695$45K0.0%-93.8%0.154% 4/30/2024 Fortis Group Advisors LLC13,999$25K0.0%N/A0.087% 2/20/2024MSD Partners L.P.15,151,516$1.07M0.1%-33.3%94.402% 2/9/2024 Commerce Bank437,000$31K0.0%-4.8%2.723% 2/2/2024 Magnolia Capital Advisors LLC401,507$28K0.0%-7.3%0.167% 11/4/2023 Magnolia Capital Advisors LLC432,969$56K0.1%N/A0.180% 7/20/2023Allred Capital Management LLC253,000$129K0.1%+24.6%0.105% 5/12/2023 CIBC Private Wealth Group LLC50,400$32K0.0%+65.8%0.021% Get the Latest News and Ratings for TCRT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/21/2023 Chiron Capital Management LLC81,830$52K0.0%-22.7%0.034% 2/15/2023Allred Capital Management LLC193,000$125K0.1%+22.2%0.089% 2/14/2023Discovery Capital Management LLC CT16,185,998$10.51M1.5%+10.5%7.487% 2/13/2023 GSA Capital Partners LLP957,348$621K0.1%+57.4%0.443% 1/30/2023 Welch Group LLC43,000$28K0.0%-26.7%0.020% 1/9/2023 Addison Capital Co15,870$2.32M1.5%N/A0.007% 11/15/2022Laurion Capital Management LP4,220,500$7.26M0.0%-1.6%1.952% 11/15/2022 Magnolia Capital Advisors LLC418,569$720K0.6%+25.1%0.194% 11/15/2022Boxer Capital LLC1,500,000$2.58M0.1%N/A0.694% 11/15/2022Caxton Associates LP311,974$537K0.1%+209.8%0.144% 11/14/2022 Zacks Investment Management44,550$77K0.0%N/A0.021% 11/14/2022Tudor Investment Corp Et Al39,374$68K0.0%-88.1%0.018% 11/14/2022Cubist Systematic Strategies LLC349,867$602K0.0%+4,589.3%0.162% 11/14/2022Ergoteles LLC485,434$835K0.0%-48.2%0.225% 11/14/2022E Fund Management Co. Ltd.15,167$26K0.0%N/A0.007% 11/7/2022 Virtu Financial LLC74,592$128K0.0%N/A0.035% 11/3/2022 Mutual Advisors LLC22,095$38K0.0%-40.4%0.010% 11/3/2022 Barclays PLC136,136$234K0.0%N/A0.063% 10/31/2022Concorde Asset Management LLC35,500$61K0.1%N/A0.016% 10/31/2022 Green Square Capital Advisors LLC1,080,000$1.86M0.3%N/A0.500% 10/26/2022 Belvedere Trading LLC66,493$78K0.0%N/A0.031% 10/24/2022 ACT Wealth Management LLC38,476$66K0.0%N/A0.018% 10/17/2022SevenBridge Financial Group LLC20,000$34K0.0%N/A0.009% 10/14/2022 Private Advisor Group LLC119,374$206K0.0%N/A0.055% 10/13/2022 Chiron Capital Management LLC116,860$201K0.1%N/A0.054% 10/13/2022 Welch Group LLC58,700$101K0.0%N/A0.027% 10/11/2022Sugarloaf Wealth Management LLC79,050$136K0.0%N/A0.037% 10/4/2022 AdvisorNet Financial Inc42,329$73K0.0%N/A0.020% 8/16/2022Discovery Capital Management LLC CT14,125,079$17.52M2.3%N/A6.541% 8/15/2022Laurion Capital Management LP4,289,193$5.32M0.1%N/A1.986% One stock to replace Nvidia (Ad)Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.Click to get the full details on Eric Fry's "Nvidia alternative" right here.8/15/2022Kettle Hill Capital Management LLC344,400$427K0.1%N/A0.159% 8/12/2022 Commerce Bank459,000$569K0.0%N/A0.213% 8/10/2022Synovus Financial Corp33,000$41K0.0%N/A0.015% 8/8/2022 Nicolet Advisory Services LLC21,500$30K0.0%N/A0.010% 8/8/2022 Oppenheimer & Co. Inc.45,500$56K0.0%N/A0.021% 8/8/2022 Y Intercept Hong Kong Ltd25,079$31K0.0%N/A0.012% 8/5/2022Gamble Jones Investment Counsel61,000$76K0.0%N/A0.028% 8/5/2022 Horizon Kinetics Asset Management LLC34,000$42K0.0%N/A0.016% 8/4/2022 Steward Partners Investment Advisory LLC36,106$45K0.0%N/A0.017% 8/3/2022 CIBC Private Wealth Group LLC41,490$51K0.0%N/A0.019% 8/3/2022 Stephens Inc. AR25,162$31K0.0%N/A0.012% 8/3/2022 Janney Montgomery Scott LLC82,412$101K0.0%N/A0.038% (Data available from 1/1/2016 forward) TCRT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TCRT shares? During the previous two years, the following institutional investors and hedge funds held shares of Alaunos Therapeutics shares: MSD Partners L.P. ($325K), Magnolia Capital Advisors LLC ($45K), Commerce Bank ($31K), and Virtu Financial LLC ($28K), Fortis Group Advisors LLC ($25K).Learn more on Alaunos Therapeutics' institutional investors. What percentage of Alaunos Therapeutics' stock is owned by institutional investors? 27.72% of Alaunos Therapeutics' stock is owned by institutional investors. Learn more on TCRT's institutional investor holdings. Which institutional investors have been buying Alaunos Therapeutics' stock? The following institutional investors have purchased Alaunos Therapeutics' stock in the last 24 months: Magnolia Capital Advisors LLC ($432.97K), Virtu Financial LLC ($15.44K), and Fortis Group Advisors LLC ($14.00K). Which of Alaunos Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Alaunos Therapeutics stock in the last 24 months: MSD Partners L.P. ($909.09K). How much institutional selling is happening at Alaunos Therapeutics? Institutional investors have sold a total of 909,091 shares in the last 24 months. This volume of shares sold represents approximately $2.93M in transactions. Related Companies Relmada Therapeutics Major Shareholders NeuroSense Therapeutics Major Shareholders Chemomab Therapeutics Major Shareholders Hoth Therapeutics Major Shareholders Passage Bio Major Shareholders BioXcel Therapeutics Major Shareholders Aspire Biopharma Major Shareholders Lexaria Bioscience Major Shareholders Abpro Major Shareholders BioLineRx Major Shareholders This page (NASDAQ:TCRT) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alaunos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alaunos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.